Fibrinogen in Haemorrhage of Delivery — FIDEL

Post-Partum Hemorrhage Clinical Trial

Official title:
Study on the Efficacy and Safety of a Therapeutic Strategy of PPH Comparing Early Administration of Human Fibrinogen vs Placebo in Patients Treated With IV Prostaglandins Following Vaginal Delivery

Status Completed

Clinical Trial Summary

The purpose of the study is to assess the benefits of a therapeutic strategy that associates an early administration of human fibrinogen concentrate in the management of PPH on the reduction of bleeding after the initiation of prostaglandins intravenous infusion, following vaginal delivery.

Clinical Trial Description

Randomised, double-blind,multicenter, placebo-controlled study ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02155725
Study type	Interventional
Source	Laboratoire français de Fractionnement et de Biotechnologies
Contact
Status	Completed
Phase	Phase 4
Start date	April 10, 2014
Completion date	August 6, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02362945` - Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic	Phase 3
Completed	`NCT02815605` - Risk Factors, Management and Complications of Severe Post-partum Hemorrhage
Recruiting	`NCT05598502` - REBOA in Life-threatening Postpartum Hemorrhage (PPH) in Uganda	N/A
Completed	`NCT01480544` - Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)	N/A
Completed	`NCT06002256` - Mostafa Maged Maneuver in Comparison With Bimanual Uterine Compression to Control Post-partum Hemorrhage	N/A
Completed	`NCT01630187` - Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section	Phase 4